Newsweek13m
Drinking Water Recall Update as FDA Changes Status
The U.S. Food and Drug Administration (FDA) terminated a recall for Berkeley Club Beverages water on November 13 and ...
MassDevice2m
Think Surgical wins another FDA clearance for its surgical robot
Think Surgical announced today that it received FDA 510(k) clearance to use its TMINI surgical robot with the LinkSymphoKnee.
Money Talks News on MSN4h
FDA Proposes Pulling Ineffective Decongestant From Market
An FDA advisory committee has unanimously concluded that oral phenylephrine, a decongestant found in many cold and flu ...
Dietary Supplement Recall Update As FDA Sets Risk Level
A Vitamin B supplement has been recalled due to being incorrectly formulated with niacin rather than niacinamide.
Benefits Pro3h
Pharmacies lobby FDA for right to keep making weight-loss drugs
Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...
GlobalData on MSN6h
FDA approves Syndax’s Revuforj to treat leukaemia
The US Food and Drug Administration (FDA) has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating relapsed or ...
Targeted Oncology2h
FDA Clears Spectral 4DCT for Precision in Radiation Oncology
The FDA-cleared Spectral CT 7500 RT, a detector-based computed tomography radiotherapy solution aimed to enhance radiation ...
MassDevice2h
BrightHeart earns FDA clearance for AI-powered prenatal heart ultrasound tech
BrightHeart announced that it received FDA 510(k) clearance for its first AI software for prenatal ultrasound evaluations of ...
The FDA Initiated a Class III Recall on More Than 150,000 Bottles of Water
The product tested positive for Coliform, which are "considered indicators of fecal contamination and, thus, pathogenic ...
RFK Jr. vow to purge FDA sets up collision with Big Pharma
Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...
BioPharma Dive1h
Syndax secures FDA OK for new kind of leukemia drug
Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...